ArticleOrphanet journal of rare diseases2019

Safety and efficacy of mTOR inhibitor treatment in patients with tuberous sclerosis complex under 2 years of age - a multicenter retrospective study.

Afshin Saffari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.